Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc add-on therapy in protease inhibitor–treated aviremic HIV-positive patients at intermediate–low cardiovascular risk
2014-002134-31Phase 4Active
- Sponsor
- Luigi Sacco University Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of maraviroc in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Luigi Sacco University Hospital. Primary endpoint: Change in carotid intima–media thickness at 6 months. Started Oct 2014; status: active.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-002134-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002134-31.